Option chain shows key data for Sorrento Therapeutics's stock options at various strike prices and expiration dates. Traders use this information to analyze potential trades and assess market sentiment for Sorrento Therapeutics.

Sorrento Therapeutics (OTC:SRNE) Stock, Option Chain

Sorrento Therapeutics

Sorrento Therapeutics Inc is a clinical and commercial-stage biopharmaceutical company developing a portfolio of next-generation treatments for three major therapeutic areas: cancer, infectious disease, and pain. Its multimodal, multipronged approach to fighting cancer is made possible by its extensive immuno-oncology platforms, including key assets such as fully human antibodies (G-MAB library), immuno-cellular therapies (DAR-T), antibody-drug conjugates (ADCs), and oncolytic virus (Seprehvec). Sorrento is also developing potential antiviral therapies and vaccines against coronaviruses, including COVI-AMG, COVIDROPS, COVISHIELD, FUJOVEE (Abivertinib), and OQORY (Covi-MSC), and diagnostic test solutions, including COVITRACK and COVIMARK.

News

Penny Stocks

Small Cap

Intraday Update

Markets

Movers

Trading Ideas

AMAM

AMRS

AMST

CERE

CSGP

CVRX

FAMI

FVRR

GMBL

HCDI

HCKT

HOTH

HRTX

KEYS

LLAP

LNZA

LUNR

MOBQ

MTDR

NYXH

PANW

PUMP

QNRX

RELI

SRNE

THRM

TILE

TRTX

USIO

WINT

WTTR

Gainers


	Windtree Therapeutics Inc (NASDAQ: WINT) shares jumped 75.3% to $0.2921. Windtree Therapeutics has been granted U.S. patent number 11,583,540 titled &#34;Istaroxime-Containing Intravenous Formulation For The Treatment Of Acute Heart Failure.&#34;


Why Quoin Pharmaceuticals Shares Are Trading Lower By Over 40%? Here Are Other Stocks Moving In Wednesday&#39;s Mid-Day Session

Biotech

Large Cap

Health Care

General

GILD

Gilead Sciences Touts Encouraging Data From Real World Studies Of Its Flagship COVID-19 Treatment

Financing

Bankrupt Sorrento Therapeutics Secures Court Approval for $75M Financing

SORRENTO THERAPEUTICS INC by Sorrento Therapeutics, Inc.

Sorrento Therapeutics Inc

Dividends

Press Releases

Scilex Holding Company Announces that the U.S. Bankruptcy Court has Extended the Lockup Period on Shares of Scilex Dividend Stock Previously Distributed by Sorrento to its Stockholders as a Dividend to April 14, 2025

SCLX

Cantor Fitzgerald

HC Wainwright & Co.

Comments

Sorrento Therapeutics

Sorrento Therapeutics (SRNE) Options

No option chain data available. Please try again later

Popular Channels

Tools & Features

Partners & Contributors

About Benzinga